Pandemic
Page: 3
This week Fred reviews the latest school recommendations from the Centers for Disease Control and Prevention (CDC) that released a new Operational Strategy for K-12 Schools to incorporate the best available evidence at this time. The evidence suggests that many K-12 schools that have strictly implemented mitigation strategies have been able to safely open for […]
The COVID Czar This week I am talking to Peter Granick, Associate Vice President Business Services and Chief Procurement Officer for Baylor University (@Baylor), and for the last several months COVID19 czar for Baylor University coordinating their response. Peter was excited to join the Baylor community on their procurement process but found his role changed in the early […]
This week’s discussion centers on the latest trend of “Vaccine Shopping”. What’s that you ask – I had the same question. For some who are struggling with accessing appointments, worried that their appointment might be canceled, or even thinking they want to pick and choose the vaccine they get, they are booking multiple appointments. While […]
This week’s discussion centers on contact tracing and some of the complexities of doing this in a workplace or college setting. The Johns Hopkins Contact Tracing Course is a good starting place but as anyone who takes the course will discover understanding the basic principles is just a starting point and there are many factors to […]
Mental Health Challenges Sadly, we are seeing increasing rates of brain health challenges around the country and likely the world. Problems that existed before having been amplified by the pandemic and the social isolation we are all experiencing. The impact of this is not just confined to adults and employees but permeates throughout our society […]
Soundcloud Meets Rap Genius This week I am talking to Shiv Rao, MD (@ShivdevRao) is the co-founder and CEO of Abridge (@ABridgeHQ), which uses groundbreaking machine learning to help people understand the details of their care and follow through on their doctors’ advice. He is also a faculty member and practicing cardiologist at UPMC’s Heart and Vascular Institute. Shiv […]
To close out the year Fred Goldstein and I review the things that took place in 2020 in healthcare generally that includes: A renewed focus on “Surprise billing” Getting everyone including patients seamless health data access Drug pricing transparency and why the US pays so much more The FDA warns Vaping is bad for your […]
This week I am talking to Dr. Zoë McLaren, Ph.D. (@ZoeMcLaren) Associate Professor in the School of Public Policy at the University of Maryland, Baltimore County. Zoë has a broad and deep set of experiences when it comes to effectively gathering data to combat infectious disease, especially in resource-limited countries, and has commented and written on […]
Airflow in South Korean Restaurant Two studies recently released build on earlier work to inform our understanding of airflow and how it spreads the SARS-CoV-2 virus. Fred reviews the airflow in cars and highlights important actionable information on optimum means of diminishing the risk of spreading the disease to other passengers in the car and […]
Which COVID19 Test Leading up to the Thanksgiving break there was a challenge getting tested. What unfolded for some people was getting a test that provided little useful information. Sadly, with the constantly changing landscape of COVID19 determining what test you should be getting and what the results mean can be difficult. This week Fred […]
The Breakfast Club How 1 small group helped save the Fall Semester. Over the last several months I have worked with my colleagues and a number of clients on plans to safely re-open businesses and school. Along the way, we have gathered some insights that are worth sharing with others. Do you want to exit […]
We Might Already Have had a Solution to COVID19 This week I am talking with Dr Jake Reder, PhD the CEO of CeldaraMedical – am innovation incubator and accelerator focused on transforming academic innovations into medicines that cure the world’s most challenging diseases. The company was originally launched during the financial crisis and as Jake […]
This week I discuss the potential for a second wave of infection and what that could mean for businesses trying to re-open and how your testing strategy can contribute to the opening without creating a second wave. Should you do clinical screening, viral or antibody testing, and which strategies should be applied. One of the […]
Screening for Businesses This week I discuss the challenges of screening and how companies and businesses need to approach this area. How you screen, who you screen and what screening are complex issues that are dependent on your specific business its risk profile, your employee risk profiles and of course what the latest science is on the virus There […]
Celebrating a Life with Zoom I attended a Zoom Celebration of Life of a friend who died recently and while it was imperfect it was an adaptation necessary in the current circumstances, we find ourselves in especially as Funerals and weddings which are one of several examples of activities that are higher risk gatherings for […]
With a nod to “The Trouble with Tribbles” this week I am reviewing testing strategies in the context of getting back to work and responding to a question I received on LinkedIn. Guidance on who should get tested (and in some cases who is eligible to get tested as we remain under-resourced in the United […]
Protecting Yourself from COVID-19 This months episode of “News you can Use” in the traditions of “Ask Me Anything” on HealthcareNOWRadio features news from the month of February 2020 that is dominated by the Coronavirus (aka COVID-19) outbreak and discusses the upcoming HIMSS Conference You can read more about the series here and the concept of keeping up with […]
Coronavirus The statistics are jarring – as of the latest update from WHO of 77,794 confirmed (599 new) cases globally with the majority coming from China with 2,348 deaths in China and 11 outside of China. The fatality rate in the point of origin (Wuhan China) is between 2-4% but outside of this region fatality […]
